Filing Details
- Accession Number:
- 0001127602-10-028568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-19 17:19:33
- Reporting Period:
- 2010-11-18
- Filing Date:
- 2010-11-19
- Accepted Time:
- 2010-11-19 17:19:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874663 | Alkermes Inc | ALKS | Pharmaceutical Preparations (2834) | 232472830 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376548 | Elliot Ehrich | 852 Winter St. Waltham MA 02451 | Svp, R&D & Chief Medical Ofcr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-18 | 5,000 | $0.00 | 31,579 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-18 | 1,588 | $10.88 | 29,991 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2010-11-19 | 3,412 | $10.83 | 26,579 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Award | Disposition | 2010-11-18 | 5,000 | $0.00 | 5,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,000 | 2010-11-18 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Restricted stock unit award granted under the Alkermes, Inc. 2008 Stock Option and Incentive Plan. Shares subject to the award vest in equal installments over a four year period, commencing on the one year anniversary of the date of grant and annually thereafter.
Billionaire Hedge Funds
